Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Ketone doai
Reexamination Certificate
2007-01-23
2007-01-23
Wang, Shengjun (Department: 1617)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Ketone doai
C514S729000
Reexamination Certificate
active
09890969
ABSTRACT:
A preventive and therapeutic drug for a neurodegenerative disease containing, as an active ingredient, a cyclohexenone long-chain alcohol compound represented by formula (1) wherein each of R1, R2, and R3represents a hydrogen atom or a methyl group; and X represents a C10–C28 alkylene group or alkenylene group. Since the compound of the present invention exhibits excellent neurite-extension ability and an inhibition effect on disorders caused by mutation in an SOD gene, it is useful as the active ingredient of a preventive and therapeutic drug for neurodegenerative diseases, inter alia, amyotrophic lateral sclerosis, and as the active ingredient of an inhibitory drug for disorders caused by mutation in an SOD gene.
REFERENCES:
patent: 5447959 (1995-09-01), Borg
patent: 5731354 (1998-03-01), Pruss
patent: 6228893 (2001-05-01), Luu et al.
patent: 0 593 831 (1994-04-01), None
patent: WO 91/05754 (1991-05-01), None
patent: WO 94/19493 (1994-09-01), None
patent: WO 96/21438 (1996-07-01), None
patent: WO 99/08987 (1999-02-01), None
Girlanda-Junges et al, 129CA:144553, 1998.
Girlanda-Junges et al, Tetrahedron, vol. 54, pp. 7735-7748, 1998.
Girlanda-Junges et al. “Effect of Cyclohexenoic Long Chain Fatty Alcohols on Neurite Outgrowth” 1998, Tetrahedron, 54, 7735-7748.
Rosen et al. “Mutations in Cu/Zn superoxide dismutase gene are associated with familiar amyotrophic lateral sclerosis” 1993, Nature, 362, 59-62.
Céline Girlanda-Junges, et al., Tetrahadron, vol. 54, No. 27, pp. 7735-7748, “Effect of Cyclohexenonic Long Chain Fatty Alcohols on Neurite Outgrowth, Study on Structure-Activity Relationship”, Jul. 2, 1998.
V. Doppler, et al., Clinical Pharmacology, vol. 18, p. 205, “Short Term Safety Controlled Trial of SR 57746A in Amyotrophic Lateral Sclerosis”, Sep. 18, 1996.
U.S. Appl. No. 10/550,305, filed Sep. 22, 2005, Luu et al.
U.S. Appl. No. 09/890,969, filed Apr. 11, 2002, Luu et al.
Chabert Philippe
Girlanda-Junges Celine
Gonzalez de Aguilar Jose-Luis
Keyling-Bilger Florence
Loeffler Jean-Philippe
Meiji Dairies Corporation
Wang Shengjun
LandOfFree
Use of cyclohexenone long-chain alcohol for treating... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Use of cyclohexenone long-chain alcohol for treating..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Use of cyclohexenone long-chain alcohol for treating... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3739848